Market cap
$236m
End-of-day close multiplied by current shares on issue.
SEK · NZX
Seeka is an NZX-listed primary industries / horticulture company. Its latest covered result is HY26, with FY22 - HY26 of source-backed result history on Annolyse.
Latest result
HY26, released 20 August 2026
| Metric | Value | Change |
|---|---|---|
| Revenue | $305.5m | ↑ +43.6% |
| EBITDA | $86.3m | ↑ +136.9% |
| NPAT | $45.4m | ↑ +332.4% |
| Operating cash flow | $57.1m | n/m |
| OCF / EBITDA % | 66.1% | ↑ +53.8pp |
| Net debt | $119.8m | ↓ -32.3% |
| Net debt / EBITDA | 1.39x | ↓ -71.4% |
| ROE % | 13.4% | ↑ +9.6pp |
| DPS | 20.0c | — |
| Payout ratio vs NPAT % | 18.7% | — |
Source: latest published briefing (HY26, released 20 August 2026). Change compares against the prior equivalent period: HY23, released 23 August 2023.
Valuation
Trailing P/E, EV/EBITDA, price-to-book and price-to-free-cash-flow ratios combine the latest available close with filing data. They are comparative measures, not forecasts or recommendations.
The latest close and share count context for the market price.
Market cap
$236m
End-of-day close multiplied by current shares on issue.
How the market price compares with recent earnings and cash-flow inputs.
P/E
Not available
Not available for this company right now.
EPS
Not available
Not available for this company right now.
PEG
Not available
Not available for this company right now.
EV/EBITDA
Not available
Not available for this company right now.
P/FCF
Not available
Not available for this company right now.
P/B
0.7x
Market value compared with latest reported equity.
Yield and investment-company valuation where supported.
Dividend yield
8.5%
Trailing dividends compared with the latest close.
Total return
Not available
Available once dividend and adjustment data are verified.
Daily closes use the full available width, with hover and touch values for each observation. Expand the chart to see more detail.
Five years of daily closes, as at close, 5 June 2026. Weekends, suspensions, and listing gaps stay as natural gaps in the time scale.
Filing-period markers only: EOD close on or before each release date divided by filing-derived trailing NPAT where both inputs verify.
Chat
Ask follow-up questions about Seeka's latest result and company history.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Financial history
The latest period is shown first.
| Metric | HY266 MONTHS20 August 2026 | FY2512 MONTHS27 February 2026 | FY2412 MONTHS27 February 2025 | FY2312 MONTHS28 February 2024 | HY236 MONTHS23 August 2023 | FY2212 MONTHS23 February 2023 | Trend |
|---|---|---|---|---|---|---|---|
| Revenue | $305.5m | $439.6m | $411.4m | $300.9m | $212.7m | $348.4m | Chart |
| Revenue growth % | -0.8% | 6.9%Outside range low revenue growth. 6.9%; 3-period range 12.5% to 41.5%. Revenue growth: 6.9%, below normal range; 3-period mean 30.2%, range 12.5%-41.5%. | 36.7% | 41.5%Outside range high revenue growth. 41.5%; 3-period range 6.9% to 36.7%. Revenue growth: 41.5%, above normal range; 3-period mean 18.7%, range 6.9%-36.7%. | -14.0% | 12.5% | Chart
|
| EBITDA | $86.3m | $95.9m | $76.1m | $26m | $36.4m | $46.1m | Chart |
| EBITDA margin % | 28.3% | 21.8%Outside range high ebitda margin. 21.8%; 3-period range 8.6% to 18.5%. EBITDA margin: 21.8%, above normal range; 3-period mean 13.5%, range 8.6%-18.5%. | 18.5% | 8.6%Outside range low ebitda margin. 8.6%; 3-period range 13.2% to 21.8%. EBITDA margin: 8.6%, below normal range; 3-period mean 17.8%, range 13.2%-21.8%. | 17.1% | 13.2% | Chart
|
| PBT | $62.6m | $47.5m | $29.7m | -$21m | $13.6m | $7.6m | Chart |
| PBT growth % | 5.4% | 59.9% | — | — | -54.8% | -67.7% | Chart |
| NPAT | $45.4m | $32m | $8.8m | -$14.5m | $10.5m | $6.5m | Chart |
| NPAT growth % | 20.1% | 263.6% | — | — | -51.2% | -56.4% | Chart |
| Operating cash flow | $57.1m | $79m | $66m | $2.7m | $4.5m | $12.1m | Chart |
| OCF / EBITDA % | 66.1% | 82.4% | 86.8%Outside range high ocf / ebitda cash conversion. 86.8%; 3-period range 10.3% to 82.4%. OCF / EBITDA cash conversion: 86.8%, above normal range; 3-period mean 39.7%, range 10.3%-82.4%. | 10.3%Outside range low ocf / ebitda cash conversion. 10.3%; 3-period range 26.3% to 86.8%. OCF / EBITDA cash conversion: 10.3%, below normal range; 3-period mean 65.2%, range 26.3%-86.8%. | 12.3% | 26.3% | Chart
|
| FCF pre-lease | $42.1m | $57.9m | $47.7m | -$20.1m | -$9.4m | -$17.6m | Chart |
| DPS | 20.0c | 25.0c | 5.0c | — | — | 0.0c | Chart |
| Payout ratio vs NPAT % | 18.7% | 32.9% | 23.8% | — | — | — | Chart |
| Annual payout ratio vs EPS % | — | 32.9% | 23.8% | — | — | — | Chart |
| ROE % | 13.4% | 10.7% | 3.3% | -5.6% | 3.8% | 2.4% | Chart |
| Net debt | $119.8m | $100.3m | $137.3m | $172.4m | $177m | $147.4m | Chart |
| Net debt / EBITDA | 1.39x | 1.05xOutside range low net debt / ebitda. 1.05x; 3-period range 1.8x to 6.63x. Net debt / EBITDA: 1.05x, below normal range; 3-period mean 3.88x, range 1.80x-6.63x. | 1.8x | 6.63xOutside range high net debt / ebitda. 6.63x; 3-period range 1.05x to 3.2x. Net debt / EBITDA: 6.63x, above normal range; 3-period mean 2.02x, range 1.05x-3.20x. | 4.86x | 3.2x | Chart
|
| Debtor days | 34 | 11 | 16 | 27Outside range high debtor days. 27d; 3-period range 0d to 16d. Debtor days: 27.1 days, above normal range; 3-period mean 8.9 days, range 0.0 days-15.6 days. | 37 | n/m | Chart
|
| Inventory days | 19 | 9 | 9 | 13 | 13 | 13 | Chart |
| Total assets | $684.8m | $605.4m | $549.9m | $548.8m | $582.7m | $547.9m | Chart |
Reference: annolyse.ai/companies/sek
Note: Figures are shown as reported. Half-year and full-year absolute values are not directly comparable. Growth rates and ratios are the meaningful comparison across mixed periods.
These charts use verified published filing periods only. Gaps are not interpolated, and mixed half-year/full-year histories are split into separate series.
Reported revenue across covered periods.
Like-period revenue growth where comparable.
Company-specific earnings measure where disclosed.
EBITDA-equivalent margin where revenue and earnings are source-backed.
Statutory profit after tax.
Cash generated from operations.
Additional filing-backed metrics for this company. Each point links to the relevant published briefing.
Cash conversion against earnings.
Operating cash flow less capex before leases.
Return on equity.
Borrowings less cash; negative values indicate net cash.
Leverage ratio, suppressed where earnings are not meaningful.
Dividend per share declared for the period.
Dividend payout against statutory NPAT.
Receivables days where the working-capital inputs are source-backed.
Inventory days where the working-capital inputs are source-backed.
Per-period working-capital absorption or release, from the same published history. Positive values are working-capital build; negative values are release.
The setup & the reality
The latest result is checked against what the prior briefing said to watch.
Historical setup
Previous analysisFY25Result releasedAnnolyse analysis published
From PBT up 59.9% on margin expansion; NPAT growth of 264% flattered by tax
The release contains no explicit FY26 earnings guidance or revenue target, so the result cannot be benchmarked against stated ambition. Operational disclosures (47m NZ kiwifruit trays packed, up 10%; Australian volumes up 25%) provide volume context but no quantified forward-work indicator. HY25 contributed 48.4% of full-year revenue but only 38.0% of EBITDA and 32.8% of NPAT, confirming a heavily second-half-weighted earnings shape consistent with the harvest cycle. The central uncertainty is whether the step-up in post-harvest gross margin to 37.9% holds in a year that may not benefit from the same volume and mix conditions.
Open questions
This briefing cannot assess whether the post-harvest margin expansion reflects durable structural gains or favourable harvest-year economics that will not repeat.
Primary issuer documents used for the HY26 briefing. Document labels are preserved from the publication record; Annolyse does not relabel every financial report as an annual report.
NZX Financial Results Announcement - 30 June 2026
HY26 / results announcementSeeka Analyst Briefing Pack - 30 June 2026
HY26 / results presentationSeeka Announcement - 30 June 2026
HY26 / results releaseSeeka Interim Report - 30 June 2026
HY26 / financial reportNZX Results Announcement - 30 June 2025
HY25 / results announcementSeeka Analyst Briefing Pack - 30 June 2025
HY25 / results presentationSeeka Announcement - 30 June 2025
HY25 / results releaseSeeka Interim Report - 30 June 2025
HY25 / financial reportNZX Results Announcement - 31 December 2025
FY25 / results announcementSeeka Analyst Briefing Pack - 31 December 2025
FY25 / results presentationSeeka Announcement - 31 December 2025
FY25 / results releaseSeeka Annual Report - 31 December 2025
FY25 / financial reportSeeka Increases Forecast Full Year Earnings Guidance
HY25 / commentaryPeer context
These companies share the same curated sub-sector label. Their reporting definitions can still differ, so compare the underlying measures before ranking them.
Archive
The full chronological archive contains every published result briefing.
HY26 · Released 20 August 2026
Profit before tax rose only 5.4% while a falling tax rate pushed NPAT growth to 20.1%, masking weaker cash generation and segment margin pressure.
FY25 · Released 27 February 2026
Post-harvest segment gross margin lifted from 26.6% to 37.9% drove the real operating gain, while a normalising tax rate amplifies the headline NPAT
FY24 · Released 27 February 2025
Revenue jumped 36.7% on a kiwifruit volume recovery, lifting PBT to NZ$29.7m from a NZ$21.0m loss, while a -70.5% effective tax rate widened the gap
FY23 · Released 28 February 2024
A NZ$24.5m working-capital release lifted operating cash, but FCF pre-lease was still NZ$-20.1m and banking support was needed.
HY23 · Released 23 August 2023
Cash conversion collapsed from 38.8% to 12.3% in Seeka's seasonally strong half, with orchard and Australian operations swinging to losses.
FY22 · Released 23 February 2023
Revenue grew 12.5% but a loss-making second half, NZ$17.6m of pre-lease cash burn and leverage at 3.2x EBITDA dominate the read.
Get the next Seeka result briefing and five-year history updates by email.